AbilTo completes Series A financing to expand proprietary technology and programs platform AbilTo.
The organization's mix of great outcomes for individuals and meaningful cost savings for health plans and employers may be the magic combination that people seek when buying healthcare technology companies. said Liam Donohue, General and Co-Founder Partner of .406 Ventures. Each AbilTo system is customized to the initial challenges the effect of a particular medical event and helps an individual learn new abilities that positively impact mental and medical health during the period of eight-weeks. In 2011, AbilTo started collaborating with Aetna, starting with the Cardiac Wellness Forum to boost patient outcomes after major heart-related events. In the two years since we applied AbilTo's strategy, participating Aetna associates have experienced, typically, a 70-80 percent reduction in depression.Related StoriesAdvances in whole mount brain imaging: an interview with Patrick Myles, President, Huron Digital PathologyBrain wellness: how can you decrease cognitive decline? An interview with Heather Snyder, Ph.D.Liposomal sizing and the Coulter principle: an interview with Professor Melvin E. KlegermanBy merging recordings of both EEG and individual neurons in trained monkeys, Whittingstall and Logothetis found that a combination of specific waves in the EEG could indeed reliably predict the experience of cells in the mind.